RESQCPR SYSTEM

FDA Premarket Approval P110024

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the resqcpr system. This device is indicated for use as a cpr adjunct to improve the likelihood of survival in adult patients with non-traumatic cardiac arrest.

DeviceRESQCPR SYSTEM
Generic NameCombination Compression/decompression Manual Chest Pump With Impedance Respiratory Valve
ApplicantADVANCED CIRCULATORY SYSTEMS, INC.
Date Received2011-06-15
Decision Date2015-03-06
Notice Date2015-03-19
PMAP110024
SupplementS
Product CodePIZ 
Docket Number15M-0738
Advisory CommitteeCardiovascular
Expedited ReviewYes
Combination Product No
Applicant Address ADVANCED CIRCULATORY SYSTEMS, INC. 1905 County Road C West roseville, MN 55113
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P110024Original Filing
S003 2021-08-25 Real-time Process
S002
S001 2015-05-12 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.